Clinical Trial Update: Tetravalent Chimeric Dengue Vaccine Trial [Phase 1]

View source ↗

Summary

Phase 1 trial of a tetravalent chimeric dengue vaccine has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Tetravalent chimeric dengue vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue | Phase 1 | Status: COMPLETED